Inscripta Stock
Inscripta is a gene editing technology company.
Sign up today and learn more about Inscripta Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Inscripta Stock
Inscripta is a gene-editing technology company that puts researchers in control by making it easy for them to get all they need for cutting-edge, forward cell-engineering. These tools include a family of CRISPR enzymes (called MADzymes), custom nucleases for researchers and commercial partners, and a full suite of gene-editing tools (instruments, reagents, and software) that will significantly increase the speed and efficiency of multiplexed, precision gene editing. By removing the barriers to forward cell engineering and gene-editing research, Inscripta will usher in a new era of advances to revolutionize how we feed, fuel, and heal humanity. Inscripta is led by several genomic technology veterans including CEO Kevin Ness, who co-founded QuantaLife and 10x Genomics, and John Stuelpnagel, the chairman of the company's board, who was co-founder and first CEO of Illumina and chairman of 10x Genomics. Inscripta is headquartered in Boulder, Colo.; has offices in Pleasanton, Calif.; and is backed by Venrock, MLS Capital, NanoDimension, Foresite, Paladin Capital Group, and Mérieux Développement.
Investors
NanoDimension
Funding History
| April 2016 | $6.0M |
|---|---|
| February 2017 | $23.1M |
| February 2018 | $55.5M |
| January 2019 | $50.0M |
| November 2019 | $175M |
| March 2021 | $150M |
Management
General Counsel
Dianna DeVore
VP Finance
Eric Warnecke
CSO & Founder
Ryan T Gill
VP Product Development
Michael Graige
VP Software
Todd Rubano
VP Biology
Paul Hardenbol
Executive Director of Data Science
Richard Fox
CEO
Kevin Ness
CTO, VP R&D, Co Founder
Tanya Lipscomb
VP Engineering
Don Masquelier
Press
forbes - Jan, 25 2023
Inscripta Is Reimagining What The Synthetic Biology Company Of The Future Will Beendpts - Jan, 20 2023
In bid to advance manufacturing capabilities, Inscripta buys out two biotechsgenomeweb - Jan, 19 2023
Inscripta Acquires Infinome Biosciences, Sestina Bioagfundernews - Jan, 12 2023
Inscripta Acquires Former Illumina Team via Solana Biosciences to Commercialize Gene Editing Toolsbizwest - Dec, 20 2022
Inscripta to close Boulder HQ, triggering ‘mass layoff’genomeweb - Dec, 10 2022
Inscripta Lays Off Dozens, Closes Colorado Headquarters, San Diego Officeendpts - May, 17 2022
Aldevron and Inscripta ink manufacturing deal for CRISPR Type-V nucleasebiospace - Jan, 11 2022
Ginkgo Bioworks Adopts Inscripta’s Onyx Digital Genome Engineering Platform to Continue Accelerating its Genome Editing Throughputbiospace - Jan, 5 2022
Inscripta® Appoints Kristala Prather, PhD to its Board of Directorssynbiobeta - Dec, 20 2021
Software Quality Assurance Engineer, Inscripta, Pleasanton, CA or Boulder, COsynbiobeta - Dec, 20 2021
Bioinformatics Software Engineer/ Senior Engineer, Inscripta, Remote U.S.synbiobeta - Dec, 3 2021
Research Associate/Senior Research Associate, Inscripta, Boulder, COsynbiobeta - Dec, 3 2021
Scientist, Inscripta, Pleasanton, CAsynbiobeta - Dec, 3 2021
Director/Senior Director, Mammalian Cell Biology, Inscripta, Boulder, COsynbiobeta - Nov, 11 2021
Scientist/ Senior Scientist, Inscripta, Pleasanton, CAgenomeweb - Oct, 15 2021
Inscripta Licenses MAD7 CRISPR Nuclease to Hunterian Medicinesynbiobeta - Oct, 8 2021
Research Associate/Senior Research Associate Boulder, Inscripta, COsynbiobeta - Oct, 6 2021
Amyris Partners with Inscripta to Enhance Development of Sustainable Ingredients Using the Onyx™ Genome Engineering Platformsynbiobeta - Oct, 6 2021
Mechanical Engineer, Inscripta, Boulder, COsynbiobeta - Sep, 29 2021
Vice President, Engineering, Inscripta, Boulder CO, San Diego or Pleasanton CAsynbiobeta - Sep, 18 2021
Scientist/Senior Scientist, Inscripta, Boulder, COsynbiobeta - Sep, 15 2021
Account Executive, Inscripta, NY/NJ/PAsynbiobeta - Sep, 15 2021
Account Executive, Inscripta, USsynbiobeta - Sep, 13 2021
Senior Process Engineer, Inscripta, San Diego, CAsynbiobeta - Aug, 25 2021
Scientist/ Senior Scientist, Inscripta, Pleasanton, CAsynbiobeta - Aug, 12 2021
Software Quality Assurance Engineer, Inscripta, Boulder, CO or Pleasanton, CAsynbiobeta - Jul, 31 2021
Senior Scientist, Inscripta, Boulder, CO,synbiobeta - Jul, 23 2021
Applications Director, Mammalian, Inscripta, Boulder, COsynbiobeta - Jul, 9 2021
Senior Staff Systems Engineer, Inscripta, Boulder, COsynbiobeta - Jul, 9 2021
Biological Data Scientist, Inscripta, Remotesynbiobeta - Jun, 29 2021
Scientist – Enzyme Engineering, Inscripta, Pleasanton, CAsynbiobeta - Jun, 29 2021
Engineering Technician, Inscripta, Boulder, COsynbiobeta - Jun, 9 2021
Senior Engineer, Inscripta, Pleasanton, CA or Boulder, COsynbiobeta - May, 25 2021
Field Service Engineer: Inscripta – Midwest, USsynbiobeta - May, 8 2021
Senior Scientist (Applications Research): Inscripta – Boulder, COsynbiobeta - Apr, 29 2021
Firmware Engineer: Inscripta – Pleasanton, CAsynbiobeta - Apr, 29 2021
Senior Research Associate (Mammalian Cell Biology): Inscripta – Boulder, COsynbiobeta - Apr, 28 2021
Scientific Project Manager: Inscripta – Remotesynbiobeta - Apr, 24 2021
Vice President (Biology): Inscripta – Pleasanton, CAsynbiobeta - Apr, 21 2021
Applications Director (Mammalian): Inscripta – Boulder, COtinyurl - Apr, 21 2021
Colorado’s Life Sciences Ecosystem Achieves Record Q1 Fundraisinggenomeweb - Apr, 6 2021
Inscripta Closes $150M Series E Financing Roundtinyurl - Apr, 6 2021
Having shipped its first benchtop gene editing devices, Inscripta draws another $150M from deep investor wellsynbiobeta - Apr, 5 2021
Scientist (Cell Biology): Inscripta – Boulder, COsynbiobeta - Apr, 5 2021
Field Applications Scientist (FAS): Inscripta – Europesynbiobeta - Apr, 5 2021
Field Service Engineer (FSE): Inscripta – North America Eastsynbiobeta - Apr, 5 2021
Technical Service Manager: Inscripta – Pleasanton, CAgenomeweb - Apr, 5 2021
Inscripta Closes $150M Series E Financing Roundpharmiweb - Apr, 5 2021
Inscripta Announces the First Commercial Shipment of Its Onyx™ Digital Genome Engineering Platform and Closes $150 Million in New Financingsynbiobeta - Mar, 31 2021
Research Associate/Sr. Research Associate: Inscripta – Boulder, COsynbiobeta - Feb, 13 2021
Staff/Principal Chemist: Inscripta – Boulder, COsynbiobeta - Feb, 10 2021
Systems Integration Summer Intern: Inscriptasynbiobeta - Feb, 9 2021
Scientist (Mammalian Cell Biology): Inscripta – Pleasanton, CAsynbiobeta - Jan, 27 2021
Field Applications Scientist (FAS): Inscripta – North America, Westsynbiobeta - Jan, 27 2021
Lab Automation Scientist: Inscripta – Pleasanton, CAsynbiobeta - Jan, 23 2021
Scientist (Cell Biology): Inscripta – Boulder,COsynbiobeta - Jan, 15 2021
Staff Scientist: Inscripta – Pleasanton, CAsynbiobeta - Jan, 13 2021
Software Quality Assurance Engineer: Inscripta – Pleasanton, CAsynbiobeta - Jan, 13 2021
Senior Systems Engineer : Inscripta – Boulder COsynbiobeta - Jan, 13 2021
Senior Director of Data Science: Inscripta – United Statessynbiobeta - Jan, 5 2021
Bioinformatics Scientist: Inscripta – Pleasanton, CAsynbiobeta - Jan, 5 2021
Technical & Marketing Writer: Inscripta – Boulder, COsynbiobeta - Jan, 1 2021
Field Applications Scientist: Inscripta – Europesynbiobeta - Dec, 15 2020
Account Executive: Inscripta – UK and BNLsynbiobeta - Dec, 11 2020
Staff Scientist – Mammalian Cell Biology: Inscripta – Boulder, COsynbiobeta - Nov, 26 2020
Senior Scientist – Analytical Biochemistry: Inscripta – Pleasanton, Californiasynbiobeta - Nov, 11 2020
Senior Scientist, Biochemistry: Inscripta – Pleasanton, CAsynbiobeta - Nov, 5 2020
Staff Engineer, Process Development: Inscripta – San Diego, CAbit - Oct, 28 2020
Inscripta Appoints Sri Kosaraju as President and CEOsynbiobeta - Sep, 21 2020
Director of Applications Development – Synthetic Biology: Inscripta – Boulder, COsynbiobeta - Sep, 21 2020
Senior Director of Data Science – Applications Development: Inscripta – Fully Remotesynbiobeta - Aug, 16 2020
Senior Instrument Control Software Engineer: Inscripta – Pleasanton, CAsynbiobeta - Aug, 5 2020
Cell Biology (Microbe): Inscripta – Boulder, COsynbiobeta - Jul, 23 2020
Data Scientist: Inscripta – Remote Workernanalyze - Mar, 23 2018
A Few Updates on the Progress of Gene Editinggenomeweb - Feb, 28 2018
Inscripta Makes New CRISPR Enzyme Free for Researchersreuters - Feb, 28 2018
Gene-editing startup Inscripta raises $55.5 millionfortune - Feb, 28 2018
This Startup Wants to Democratize CRISPR Gene Editing Research By Making It FreeForbes - Dec, 13 2017
This Startup Has a New CRISPR Enzyme -- And Says It Will Give It Away For FreeEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
